Download the free

Alpha-1 antitrypsin deficiency

case study

Sano worked with an industry-leading Sponsor to rapidly deliver genetically qualified volunteers for a precision medicine clinical study in Alpha-1 antitrypsin deficiency.

The primary genetic variant desired by the client is only present in 1 in 3,000 Europeans and is even rarer in non-Europeans.

Copy of main image-1

Key Highlights

Group 341
65 genetically qualified referrals 
Group 342

90% of the referral target delivered within 1 month of the agreed 4 month recruitment period